JUN and nasopharyngeal carcinoma: The combined treatment of hellebrigenin with mitogen‐activated protein kinase inhibitors revealed the involvement of the extracellular signal–regulated kinases and c‐Jun N‐terminal kinases pathways in hellebrigenin‐induced apoptosis in NPC cells.